Top 30 Life Science VC Funds & Investors in Italy (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Sofinnova Partners
VC Fund
|
4 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
CDP Venture Capital
VC Fund
|
4 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $483k–$23M |
|
Indaco Venture Partners
VC Fund
|
3 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
Claris Ventures
VC Fund
|
2 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.1M–$23M |
|
Italian Angels for Growth
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Club degli Investitori
VC Fund
|
2 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, E-Commerce | $197k–$30M |
|
Principia SGR
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Lazio Innova
VC Fund
|
1 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Biotechnology | $22k–$1.9M |
|
Gresilent Holdings
VC Fund
|
1 | Seed | |||
|
Farming Future
VC Fund
|
1 | Italy | Seed, Pre-Seed | Agriculture, AgTech, Hardware | $657k–$2.3M |
|
ToSeed & Partners
VC Fund
|
1 | Italy | Seed, Venture - Series Unknown | Agriculture, Food and Beverage, Water | $657k–$1.3M |
|
AbbVie
VC Fund
|
1 | United States, China, Italy | Series A, Grant, Seed | Health Care, Biotechnology, Medical | $4M–$85M |
|
Ligurcapital SpA
VC Fund
|
1 | Italy | Seed, Debt Financing | Fashion, Internet, E-Commerce | $274k–$1.4M |
|
Gaiae International
VC Fund
|
1 | Italy | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
Sparta Capital
VC Fund
|
1 | Italy, Germany, Luxembourg | Series A, Series B | Renewable Energy, Solar, Automotive | $11M–$16M |
|
ReItaly21
VC Fund
|
1 | Italy | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
MCF Holding
VC Fund
|
1 | Italy | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
JDRF T1D Fund
VC Fund
|
1 | United States, Canada, France | Series A, Series B | Biotechnology, Health Care, Medical | $7M–$130M |
|
Deep Blue Ventures
VC Fund
|
1 | Italy | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
Invitalia Ventures
VC Fund
|
1 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, B2B | $658k–$6.2M |
|
LIFTT
VC Fund
|
1 | Italy, United Kingdom, France | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Manufacturing | $255k–$118M |
|
ENEA Tech e Biomedical
VC Fund
|
1 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
EIT Food
VC Fund
|
1 | United Kingdom, Israel, Germany | Grant, Non-Equity Assistance, Seed | Biotechnology, Food and Beverage, Food Processing | $1.2k–$9.7M |
|
CDP Equity
VC Fund
|
1 | Italy, United Kingdom | Series A, Seed, Pre-Seed | SaaS, Events, Education | $2.3M–$13M |
|
Pariter Partners
VC Fund
|
1 | Italy, Switzerland | Seed, Venture - Series Unknown | Electronics, Manufacturing, Industrial Automation | $796k–$1.6M |
|
Blue Ocean Finance
VC Fund
|
1 | Italy | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
Utopia
VC Fund
|
1 | Italy | Seed, Pre-Seed | Biotechnology, Genetics, Health Care | $1.4M–$2M |
|
AbbVie Biotech Ventures
VC Fund
|
1 | United States, China, Italy | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$115M |
|
Roche Venture Fund
VC Fund
|
1 | United States, United Kingdom, Spain | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$125M |
|
Kairos Ventures
VC Fund
|
1 | United States, India, Italy | Seed, Series A | Biotechnology, Health Care, Therapeutics | $1.6M–$20M |
| Access all 49 VC funds in Italy Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 329
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 295
- Round size: Seed $483k–$7.7M; Series A $3.3M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $2.1M–$11M; Series A $6.1M–$23M; Series B $7.4M–$21M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Lever Bio — Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Haptena Therapeutics — Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering. Our research focuses on KRAS-mutant tumors to deliver more effective and durable treatment options.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $329k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana — Autonomous systems for enterprise
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 114
- Round size: Seed $197k–$8.2M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $400k–$1.9M; Grant $22k–$121k; Pre-Seed $53k–$518k
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Gresilent Holding is Erba's Family office and Investment Arm. The sectors we focus on are SAAS/Cloud + AI, Green Tech (with a particular interest in Nuclear Fusion and Agro Tech), Next-Gen Healthcare, New Therapies and Longevity, and Deep Tech (with a specific interest in Quantum Computing and space)
Show more...Investment focus
- Stage:Seed
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Farming Future is the national technology transfer hub founded on the initiative of CDP venture capital in partnership with toseed and partners.
Show more...Investment focus
- Industry: Agriculture, AgTech, Hardware
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 11
- Round size: Seed $657k–$2.3M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- Aflabox — Aflabox develops food contaminant detection devices utilizing NIR spectroscopy and advanced image processing that uses AI analysis.
- Yeastime — Discover how ultrasound can improve the fermentation process by up to 30% with our innovative solutions.
- VisioNing — VisioNing is a cleantech company that offers proprietary technology solutions for treatment and valorization of agro-industrial wastewater.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Toseed Venture Capital of the CDP network, created by Luigi Galimberti and Giovanni Ferri, supports innovative projects in Agrifood tech
Show more...Investment focus
- Industry: Agriculture, Food and Beverage, Water
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $657k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Aflabox — Aflabox develops food contaminant detection devices utilizing NIR spectroscopy and advanced image processing that uses AI analysis.
- Yeastime — Discover how ultrasound can improve the fermentation process by up to 30% with our innovative solutions.
- VisioNing — VisioNing is a cleantech company that offers proprietary technology solutions for treatment and valorization of agro-industrial wastewater.
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Grant, Seed
- Geography: United States, China, Italy
Investor stats
- Total investments: 50
- Round size: Seed $4M–$42M; Series A $7M–$85M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
- Endlyz Therapeutics — ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Ligurcapital is a public and private joint venture that offers equity financing to companies in Liguria, Italy.
Show more...Investment focus
- Industry: Fashion, Internet, E-Commerce
- Stage:Seed, Debt Financing
- Geography: Italy
Investor stats
- Total investments: 6
- Round size: Seed $274k–$1.4M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Wikicasa — Scegli tra migliaia di annunci di case in vendita completi, aggiornati e affidabili. Per trovare velocemente la tua futura casa con Wikicasa!
- React4life — React4life is an Italian biotech company founded in 2016 after more than 15 years of R&D by Silvia Scaglione and Maurizio Aiello, together with a multidisciplinary team of experts, with the ambition to turn the promise of biomedical research into concrete benefits for society. Scientists can finally rely on a new enabling technology torecapitulate human biology in the lab: MIVO® (Multi In Vitro Organ), the next generation of organ-on-a-chip. This cutting-edge microphysiological system enables researchers to overcome the limits of current in vitro assays and animal models. It improves the reliability and predictivity of several applications: pharmaceutical drug-testing, personalized medicine, novel immuno-oncology therapies, cosmetics, dermatology, and nutraceutical. Learn more at www.react4life.com
- greenchic — A pioneer of the circular economy, greenchic is the number 1 fashion-logistics startup in Southern Europe. Send us what you wish to swap, and immediately start buying with our reward points system. Thanks to this effortless service model, greenchic offers the fastest DTC way to regain value from no longer used clothing. Through greenchic, memberscan exchange items and revamp their style in an affordable, convenient and sustainable way. With 99% of the products sold, reused, upcycled, or donated to charities within 6 months, greenchic is set to become a European leader in circular fashion. With its growing user base, the highest customer retention rate in fashion recommerce, a 4.5-star TrustPilot rating, the platform offers to its highly engaged community a collection of more than 240.000 items. Thanks to a semi-automated logistic warehouse, an event-driven serverless digital platform, and its own digital token, the startup is experiencing a 2X growth pattern and is supported by some of the best investors from the Italian fashion & social impact scene.greenchic is now operating in Italy and France.Find out more by visiting greenchic.com and following @greenchic on socials.
Gaiae International is a leading importer and exporter of fruits and vegetables.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Sparta Capital Ltd. focuses on product development, manufacturing, distribution, sales and service across a range of technologies. The Company's offering includes four different market verticals: transportation, mining, construction and energy (through biomass conversion). These offerings include optimization of energy consumption in thecommercial and manufacturing sectors, construction and energy through biomass conversion, energy conservation in mining, and energy savings in transportation. It is focused on the expansion of a range of divisions, including photoluminescent safety products division, energy audit (EMD) division, biomass division and mining division.
Show more...Investment focus
- Industry: Renewable Energy, Solar, Automotive
- Stage:Series A, Series B
- Geography: Italy, Germany, Luxembourg
Investor stats
- Total investments: 4
- Round size: Series A $11M–$16M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- B-ON — B—ON is a full-service solution provider democratizing fleet electrification, providing access to an entire ecosystem of services through one simple process. B—ON is focused on transforming last mile transportation of people and goods to zero emissions. B—ON was established in 2021.
- Sunvigo — Sunvigo provides you with cheap solar power from your roof and real green power from the grid.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
ReItaly21 is an investment firm.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
MCF Holding is a holding company of financial investments that engages in the management of events, retail, and real estate business.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Canada, France
Investor stats
- Total investments: 55
- Round size: Series A $7M–$105M; Series B $18M–$130M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Diasome Pharmaceuticals — Realizing a new life with diabetes.
- Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
- Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
Deep Blue Ventures is an international holding company that acquires, manages, and scales the next generation of online brands.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, B2B
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $255k–$7.6M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Grant, Non-Equity Assistance, Seed
- Geography: United Kingdom, Israel, Germany
Investor stats
- Total investments: 128
- Round size: Seed $226k–$9.7M; Grant $23k–$531k; Non-Equity Assistance $1.2k–$32k
- Lead/follow: 68% lead, 32% follow
Portfolio highlights
- Hooked Foods — Hooked Foods is working on a plant-based tuna substitute. By serving delicious plant-based seafood for everyone to enjoy, the company is leading the transition to a healthier seafood ecosystem. The company was established in 2019 and is headquartered in Sweden.
- Perfat Technologies — Perfect fats for better foods.
- Roslin Technologies — Roslin Tech is on a mission to improve protein production through disruptive technologies. Our core capability is in animal stem cells; we have developed the world’s perpetually self-renewing, pluripotent stem cells for animals (iPS cells) which will accelerate the development of cultivated meat for the consumer market.
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Events, Education
- Stage:Series A, Seed, Pre-Seed
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 16
- Round size: Seed $3.3M–$13M; Series A $2.3M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Gility — Gility is a digital learning platform that collaborates with business schools and training institutions for an effective training offer. Established in 2022, it was supported by CDP Venture Capital and BPER Banca.
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Valvitalia SpA. — VALVITALIA is a leading group in the field of design, production, and overall supply of equipment and components intended for the petroleum, water, natural gas industries, and petrochemical industry as well as electrical power stations. The group works mainly with valves (core product), actuators, pipe fittings, flanges and systems for measuring,filtering, and regulating fluids and gases and with FireFighting systems. VALVITALIA was set up with the precise objective of becoming the leading Italian group able to offer such a wide range of products and to compete with the large American multinationals that have always dominated this field. This young company has extensive experience in the sector, thanks to its professional management and historical brands in the valve world that have been taken on by the Group, including: ROTOR, DELTA V.E., THEVIGNOT, VANADOUR, VITAS, TORMENE T.G.T. and TECNOFORGE. VALVITALIA has always included safety and respect for the environment and its employees among its priorities.
Pariter Partners is a largest Syndicate in Italy, investing in early stage deep-tech teams and advanced service solution startups.
Show more...Investment focus
- Industry: Electronics, Manufacturing, Industrial Automation
- Stage:Seed, Venture - Series Unknown
- Geography: Italy, Switzerland
Investor stats
- Total investments: 9
- Round size: Seed $796k–$1.6M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- K3RX — K3RX products for thermal protection systems of the next generation of hypersonic vehicles and rocket motor inserts of satellite launchers demonstrate their performance. K3RX manufactures tiles in uhtcmc material, rocket nozzles, screws, nuts, and support mechanical connectors.
- Eye2Drive — Eye2Drive designs bio-inspired, AI-ready CMOS image sensors for autonomous navigation, eliminating flickering and ghosting while significantly enhancing safety.
- Fluid Wire Robotics — A fully electric robotic platform for extreme environments: nuclear, space, cryogenic, ATEX and subsea. Manipulation where conventional robots cannot go.
Blue Ocean Finance S.p.A is a financial consulting firm focusing on Italian startups and innovative SMEs. The company’s aim is to assist enterprises in achieving their objectives of growth by developing a tailored financial strategy, obtaining new capital and advising them during extraordinary business operations. Funded in Rome in 2018, BlueOcean Finance is well known for its expertise in Corporate Finance, Banking and Financial Advisory.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $1.4M–$2M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Lighthouse Biotech — Lighthouse Biotech offers a liquid biopsy tool that helps to extract live and intact circulating tumor cells from a simple blood sample, to avoid repetition with altered metabolism, helping medical staff and doctors to trace and treat tumor cells in the very early stages of the disease.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Italy
Investor stats
- Total investments: 49
- Round size: Series A $6M–$53M; Series B $12M–$85M; Series C $39M–$115M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 120
- Round size: Series A $7.5M–$86M; Series B $10M–$125M; Series C $5M–$105M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- AveXis — Discover how Novartis Pharmaceuticals brings innovative medicines to market to enhance health outcomes for patients and offer solutions to healthcare providers.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ...
Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists. Kairos Venture Investments works to get science into the hands of applicable companies.Their team possesses an extraordinary passion to have a huge impact on our world through the creation of companies that will improve our lives and that of thegenerations that will follow. They aim to do this by backing the very best scientists, engineers and entrepreneurs and help them transform their knowledge, ideas and discoveries into viable businesses. They expect these companies to have a huge impact on the world and create significant returns for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A
- Geography: United States, India, Italy
Investor stats
- Total investments: 63
- Round size: Seed $1.6M–$7.5M; Series A $3.2M–$20M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $250M in 2019
Portfolio highlights
- Alomana — Autonomous systems for enterprise
- PteroDynamics — PteroDynamics in an aircraft manufacturer that builds ultra-long-range VTOL aircraft based on its Transwing aircraft design with folding wings
- Purple Style Labs — Purple Style Labs is an IIT-Bombay graduate and ex-banker with Deutsche. It aspires to be the biggest fashion house of India managing multiple designer brands in the premium, luxury as well as affordable retail segment.
Life Science VC funding in Italy at a glance
Stats across 35 deals from 49 investors.
Access all 49 VC funds in Italy Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 49 VC funds investing in Italy Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!